Amid scrutiny around Europe's vaccine purchase, Pfizer CEO Albert Bourla pulls out of committee hearing

Following an audit report into the EU's COVID-19 vaccine procurement strategy, Pfizer CEO Albert Bourla, Ph.D., was previously due to testify before the European Parliament’s COVID-19 committee Oct. 10. Now, the leader of the pharma giant has pulled out of the appointment, Politico reports.